METANALYSIS OF CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS (PMO)

被引：0
|
作者：
CRANNEY, A
MOHER, D
SHEA, B
WELLS, G
ADACHI, R
TUGWELL, P
机构：
[1] UNIV OTTAWA,OTTAWA,ON K1N 6N5,CANADA
[2] OTTAWA GEN HOSP,OTTAWA,ON K1H 8L6,CANADA
[3] MCMASTER UNIV,HAMILTON,ON,CANADA
来源：
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1240 / 1240
页数：1
相关论文
共 50 条
  • [21] Effects of 2-year treatment with calcitonin in postmenopausal osteoporosis
    Gurer, G.
    Sendur, O. F.
    Tastaban, E.
    Aydemir, A. H.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S261 - S261
  • [22] Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis
    Body, JJ
    BONE, 2002, 30 (05) : 75S - 79S
  • [23] Long term treatment of postmenopausal osteoporosis with calcitonin, alendronate, or alphacalcidiol
    Demirel, GG
    Paker, N
    Yilmaz, H
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S181 - S181
  • [24] Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis
    Tekeoglu, I
    Adak, B
    Budancamanak, M
    Demirel, A
    Ediz, L
    RHEUMATOLOGY INTERNATIONAL, 2005, 26 (02) : 157 - 161
  • [25] COHERENCE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH GROWTH-HORMONE AND CALCITONIN
    ALOIA, JF
    VASWANI, A
    MEUNIER, PJ
    EDOUARD, CM
    ARLOT, ME
    YEH, JK
    COHN, SH
    CALCIFIED TISSUE INTERNATIONAL, 1987, 40 (05) : 253 - 259
  • [26] Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
    Downs, RW
    Bell, NH
    Ettinger, MP
    Walsh, BW
    Favus, MJ
    Mako, B
    Wang, LX
    Smith, ME
    Gormley, GJ
    Melton, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1783 - 1788
  • [27] Comparison of the effects of alendronate, risedronate and calcitonin treatment in postmenopausal osteoporosis
    Yildirim, K
    Gureser, G
    Karatay, S
    Melikoglu, MA
    Ugur, M
    Erdal, A
    Senel, K
    Billen, H
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2005, 18 (3-4) : 85 - 89
  • [28] RATIONALE FOR THE USE OF CALCITONIN IN POSTMENOPAUSAL OSTEOPOROSIS
    AVIOLI, LV
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1988, 77 (5-6) : 224 - 228
  • [29] THE EFFECT OF NASAL CALCITONIN ON POSTMENOPAUSAL OSTEOPOROSIS
    RIIS, BJ
    CHRISTIANSEN, C
    OVERGAARD, K
    ADVANCES IN GYNECOLOGICAL ENDOCRINOLOGY, VOLS 1 AND 2, 1988, : B603 - B607
  • [30] NO EVIDENCE FOR CALCITONIN DEFICIENCY IN POSTMENOPAUSAL OSTEOPOROSIS
    TIEGS, RD
    BODY, JJ
    ROLFE, J
    RIGGS, BL
    HEATH, H
    CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) : 499 - 499
12345